Q: I'm fat and I'm scared of needles. Would SKNY be a good investment? Thanks
5i Research Answer:
Needle-free delivery may be a big market one day, but SKNY is far too small at $8M for investment consideration. Its trials are only at the animal stage, and it could be decades before any approval. It will need a lot of capital to complete its trials and plans. It is, for now, just a lottery ticket and we would not endorse it.